Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-13

Clinical Trial Update: Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of a low-dose oral contraceptive pill for primary dysmenorrhea has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low-dose oral contraceptive pill

Snippet

Sponsor: Nobelpharma | Conditions: Dysmenorrhea | Phase 3 | Status: COMPLETED | Results posted: 2014-06-13